A Phase 1/2 Multicenter, Open-label Study to Assess the Safety, Pharmacokinetics and Efficacy of CC-92480 Monotherapy and in Combination with Dexamethasone in Participants with Relapsed and Refractory Multiple Myeloma

Project: Research

Project Details

Project Description

NMA HREC Reference Number: CALHN ref R20200608
NMA SSA Reference Number: SSA/70060/MonH-2021-254106(v2)
Monash Health Reference: RES-21-0000-060X
StatusActive
Effective start/end date12/01/21 → 11/01/26

Keywords

  • clinical trial
  • phase 1 and 2 study
  • treatment safety
  • treatment efficacy
  • myeloma